Cardiometabolic Disorders

Top Story

Subclinical hypothyroidism increases the risk for nonalcoholic fatty liver disease

Subclinical hypothyroidism increases the risk for nonalcoholic fatty liver disease
March 24, 2019
Meeting News

Testosterone therapy reduces CV events, death in men with hypogonadism

March 22, 2019
NEW ORLEANS — Low testosterone is associated with increased all-cause and cardiovascular mortality, and testosterone replacement therapy in men with a confirmed…
Meeting News

High-intensity interval training impacts body composition of patients with metabolic syndrome

March 20, 2019
NEW ORLEANS — High-intensity interval training led to significant reductions in total body fat, abdominal fat distribution as well as an increase in lean mass…
In the Journals

Parathyroidectomy may decrease short-term CV risk markers in primary hyperparathyroidism

March 19, 2019
Patients with mild to moderate hyperparathyroidism who underwent parathyroidectomy experienced a decrease in total cholesterol and reduced pulse wave velocity vs…
More Headlines »
CME

Individualizing the Treatment of Type 2 Diabetes With a Focus on Cardiovascular Outcomes

This activity is supported by an educational grant from the Merck/Pfizer Alliance.

Emerging clinical evidence regarding the impact of hyperglycemia on cardiovascular outcomes warrants that physicians…
More »
Video
Meeting News

VIDEO: Heart failure presents unique challenges in diabetes

July 14, 2018
More »
CME

Advancing Science in Residual Cardiovascular Risk: Will New Cardiovascular Outcomes Trials Bring a Paradigm Shift in Patient Care?

This activity is supported by an unrestricted educational grant from Amarin Pharma, Inc.

Despite therapeutic advances, cardiovascular disease (CVD) continues to be the leading cause of preventable death in…
More »